Enhancement of hypoxia-activated prodrug TH-302 anti-tumor activity by Chk1 inhibition
Fanying Meng(Shanghai University), Charles P. Hart(University of Auckland), Deepthi Bhupathi(University of Auckland), Qian Liu(Tianjin First Center Hospital), Yan Wang(Capital Medical University), Jessica D. Sun(Threshold Pharmaceuticals (United States)), Dharmendra Ahluwalia(Threshold Pharmaceuticals (United States)), Mark D. Matteucci(University of Auckland)
Cited by 24
Related Papers
Autism-like behaviours and germline transmission in transgenic monkeys overexpressing MeCP2
|Nature|2016|328
Molecular and Cellular Pharmacology of the Hypoxia-Activated Prodrug TH-302
|Molecular Cancer Therapeutics|2011|206
Oral Probiotics Ameliorate the Behavioral Deficits Induced by Chronic Mild Stress in Mice via the Gut Microbiota-Inflammation Axis
|Frontiers in Behavioral Neuroscience|2018|125